{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T07:43:27Z","timestamp":1780472607840,"version":"3.54.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaapos.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.jaapos.2005.12.002","type":"journal-article","created":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T09:01:05Z","timestamp":1141894865000},"page":"26-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Optic Neuritis Associated With Etanercept Therapy for Juvenile Arthritis"],"prefix":"10.1016","volume":"10","author":[{"given":"Tsivia","family":"Tauber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Turetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Barash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Avni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Morad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaapos.2005.12.002_bib1","first-page":"3873","article-title":"Expression of multiple cytokines and IL-1RA in the uvea and retina during endotoxin-induced uveitis in the rat","volume":"35","author":"de Vos","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2005.12.002_bib2","first-page":"3884","article-title":"The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice","volume":"35","author":"Nakamura","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaapos.2005.12.002_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/art.10710","article-title":"Long-term efficacy and safety of etanercept in children with polyarticular-course juvenile rheumatoid arthritis","volume":"48","author":"Lovell","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaapos.2005.12.002_bib4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00002281-199909000-00008","article-title":"Juvenile rheumatoid arthritis","volume":"11","author":"Gallagher","year":"1999","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib5","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/art.11155","article-title":"Long-term outcome of etanercept therapy in children with treatment-refractory uveitis","volume":"48","author":"Reiff","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaapos.2005.12.002_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/art.503","article-title":"Management of uveitis","volume":"46","author":"Smith","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaapos.2005.12.002_bib7","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaapos.2005.12.002_bib8","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1016\/mjd.2003.554","article-title":"Etanercept","volume":"49","author":"Goffe","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0955-2235(92)90022-A","article-title":"Evaluation of the role of cytokines in autoimmune disease","volume":"4","author":"Feldmann","year":"1992","journal-title":"Prog Growth Factor Res"},{"key":"10.1016\/j.jaapos.2005.12.002_bib10","first-page":"335","article-title":"Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease","volume":"8","author":"Bendtzen","year":"1989","journal-title":"Thyroid Cell Group Lymphokine Res"},{"key":"10.1016\/j.jaapos.2005.12.002_bib11","first-page":"126","article-title":"The possible role of tumor necrosis factor (TNF) and its natural inhibitors, the soluble-TNF receptors, in autoimmune diseases","volume":"28","author":"Aderka","year":"1992","journal-title":"Isr J Med Sci"},{"key":"10.1016\/j.jaapos.2005.12.002_bib12","first-page":"187","article-title":"TNF-alpha-targeted therapy in rheumatoid arthritis","volume":"66","author":"Wendling","year":"1999","journal-title":"Rev Rhum Engl Ed"},{"key":"10.1016\/j.jaapos.2005.12.002_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF00422933","article-title":"Elevated TNF receptor plasma concentrations in patients with rheumatoid arthritis","volume":"70","author":"Heilig","year":"1992","journal-title":"Clin Invest"},{"key":"10.1016\/j.jaapos.2005.12.002_bib14","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/rheumatology\/31.5.293","article-title":"TNF alpha\u2014a pivotal role in rheumatoid arthritis?","volume":"31","author":"Brennan","year":"1992","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jaapos.2005.12.002_bib16","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1210\/endo.139.7.6085","article-title":"Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro","volume":"139","author":"Lader","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.jaapos.2005.12.002_bib17","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib18","first-page":"1677","article-title":"Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis","volume":"28","author":"Takei","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1345\/aph.10123","article-title":"Etanercept in juvenile rheumatoid arthritis","volume":"35","author":"Johnson","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaapos.2005.12.002_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00002018-200225030-00004","article-title":"Safety and efficacy of disease-modifying anti-rheumatic agents","volume":"25","author":"Fleischmann","year":"2002","journal-title":"Drug Safety"},{"key":"10.1016\/j.jaapos.2005.12.002_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/09546630410017275","article-title":"A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab","volume":"15","author":"Scheinfeld","year":"2004","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.jaapos.2005.12.002_bib22","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/bjo.87.7.925","article-title":"Does etanercept induce uveitis?","volume":"87","author":"Reddy","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib23","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.62.1.88","article-title":"Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors","volume":"62","author":"Kaipiainen-Seppanen","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaapos.2005.12.002_bib24","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/art.10885","article-title":"Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type","volume":"48","author":"Quartier","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaapos.2005.12.002_bib25","first-page":"142","article-title":"Flash electroretinograms and pattern visually evoked cortical potentials in Behcet\u2019s disease","volume":"34","author":"Cruz","year":"1990","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0168-5597(94)90095-7","article-title":"Evoked potential findings in Behcet\u2019s disease","volume":"92","author":"Stigsby","year":"1994","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.jaapos.2005.12.002_bib27","first-page":"70","article-title":"Vogt-Koyanagi-Harada syndrome\u2014a case report","volume":"45","author":"Yusof","year":"1990","journal-title":"Med J Malaysia"}],"container-title":["Journal of American Association for Pediatric Ophthalmology and Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853105003149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091853105003149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:14:01Z","timestamp":1761077641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091853105003149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1091853105003149"],"URL":"https:\/\/doi.org\/10.1016\/j.jaapos.2005.12.002","relation":{},"ISSN":["1091-8531"],"issn-type":[{"value":"1091-8531","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optic Neuritis Associated With Etanercept Therapy for Juvenile Arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of American Association for Pediatric Ophthalmology and Strabismus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaapos.2005.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 American Association for Pediatric Ophthalmology and Strabismus. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}